ADGRL1
Basic information
Region (hg38): 19:14147743-14206187
Previous symbols: [ "LPHN1" ]
Links
Phenotypes
GenCC
Source:
- developmental delay, behavioral abnormalities, and neuropsychiatric disorders (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Developmental delay, behavioral abnormalities, and neuropsychiatric disorders6 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 35907405 |
ClinVar
This is a list of variants' phenotypes submitted to
- Developmental delay, behavioral abnormalities, and neuropsychiatric disorders (6 variants)
- Inborn genetic diseases (3 variants)
- Autistic behavior;Seizure;Global developmental delay;Attention deficit hyperactivity disorder (2 variants)
- Intellectual disability;Autistic behavior;Global developmental delay;Attention deficit hyperactivity disorder (2 variants)
- Global developmental delay (1 variants)
- Specific learning disability;Global developmental delay (1 variants)
- Intellectual disability;Specific learning disability;Global developmental delay (1 variants)
- Intellectual disability;Global developmental delay (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADGRL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 106 | 111 | ||||
nonsense | 8 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 12 | 5 | 108 | 6 | 1 |
Variants in ADGRL1
This is a list of pathogenic ClinVar variants found in the ADGRL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-14150892-T-G | Inborn genetic diseases | Uncertain significance (Oct 03, 2022) | ||
19-14150940-G-T | Inborn genetic diseases | Uncertain significance (Jun 16, 2024) | ||
19-14150962-G-A | Inborn genetic diseases | Uncertain significance (Apr 17, 2024) | ||
19-14150979-T-C | Inborn genetic diseases | Uncertain significance (Mar 15, 2024) | ||
19-14151030-T-A | Inborn genetic diseases | Uncertain significance (Feb 15, 2023) | ||
19-14151035-T-G | Inborn genetic diseases | Uncertain significance (Nov 08, 2022) | ||
19-14151055-C-T | Inborn genetic diseases | Uncertain significance (Nov 18, 2022) | ||
19-14151082-T-C | Inborn genetic diseases | Uncertain significance (Aug 13, 2021) | ||
19-14151085-G-C | Inborn genetic diseases | Uncertain significance (Jan 19, 2024) | ||
19-14151099-C-T | Inborn genetic diseases | Uncertain significance (Feb 08, 2023) | ||
19-14151103-C-T | Inborn genetic diseases | Uncertain significance (Jan 24, 2023) | ||
19-14151105-G-C | Inborn genetic diseases | Uncertain significance (Aug 16, 2021) | ||
19-14151115-G-A | Inborn genetic diseases | Uncertain significance (Mar 18, 2024) | ||
19-14151144-T-C | Inborn genetic diseases | Uncertain significance (Apr 25, 2022) | ||
19-14151147-A-C | Developmental delay, behavioral abnormalities, and neuropsychiatric disorders | Uncertain significance (Mar 26, 2024) | ||
19-14151148-G-C | Inborn genetic diseases | Uncertain significance (May 27, 2022) | ||
19-14151152-G-T | Uncertain significance (Nov 08, 2023) | |||
19-14151157-G-C | Inborn genetic diseases | Uncertain significance (Jun 11, 2021) | ||
19-14151180-C-T | Inborn genetic diseases | Uncertain significance (Apr 01, 2024) | ||
19-14151193-C-T | Inborn genetic diseases | Uncertain significance (Jun 30, 2022) | ||
19-14151199-C-G | Inborn genetic diseases | Uncertain significance (Nov 15, 2021) | ||
19-14151207-C-T | Inborn genetic diseases | Uncertain significance (Nov 07, 2022) | ||
19-14151229-C-T | Inborn genetic diseases | Uncertain significance (Nov 17, 2022) | ||
19-14151309-C-T | Inborn genetic diseases | Uncertain significance (Jun 29, 2023) | ||
19-14151318-C-A | Inborn genetic diseases | Uncertain significance (Jul 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADGRL1 | protein_coding | protein_coding | ENST00000340736 | 23 | 56250 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 7.15e-7 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.43 | 640 | 935 | 0.685 | 0.0000651 | 9410 |
Missense in Polyphen | 235 | 433.4 | 0.54222 | 4243 | ||
Synonymous | -1.72 | 470 | 425 | 1.11 | 0.0000323 | 3087 |
Loss of Function | 6.99 | 7 | 70.3 | 0.0996 | 0.00000411 | 695 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000359 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000349 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-independent receptor of high affinity for alpha- latrotoxin, an excitatory neurotoxin present in black widow spider venom which triggers massive exocytosis from neurons and neuroendocrine cells. Receptor for TENM2 that mediates heterophilic synaptic cell-cell contact and postsynaptic specialization. Receptor probably implicated in the regulation of exocytosis (By similarity). {ECO:0000250}.;
- Pathway
- GPCRs, Class B Secretin-like
(Consensus)
Recessive Scores
- pRec
- 0.231
Intolerance Scores
- loftool
- rvis_EVS
- -2.63
- rvis_percentile_EVS
- 0.8
Haploinsufficiency Scores
- pHI
- 0.256
- hipred
- Y
- hipred_score
- 0.715
- ghis
- 0.620
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Adgrl1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;calcium-mediated signaling using intracellular calcium source;positive regulation of synapse assembly;positive regulation of synapse maturation
- Cellular component
- plasma membrane;integral component of plasma membrane;postsynaptic density;integral component of membrane;cell junction;axon;growth cone;presynaptic membrane;neuron projection;synapse
- Molecular function
- G protein-coupled receptor activity;protein binding;latrotoxin receptor activity;carbohydrate binding;cell adhesion molecule binding